Abstract
Under most physiologic conditions encountered in modern life, glucose is the brain’s obligate fuel (Cryer, 117:868–870, 2007); therefore maintenance of blood glucose within the physiological range is of great importance. Hypoglycemic disorders, although uncommon (Service, J Clin Invest 332:1144–1152, 1995), are significant because low blood glucose leads to symptoms and signs of brain dysfunction. Profound or prolonged hypoglycemia may lead to cardiac arrhythmias, cognitive dysfunction or brain death (Cryer, N Eng J Med 117:868–870, 2007). However, the symptoms of hypoglycemia such as tachycardia, sweating, tremor, and nervousness are not specific to hypoglycemia. To diagnose a hypoglycemic disorder, it is necessary to document low blood glucose at the time of symptoms compatible with neuroglycopenia. These symptoms should be ameliorated by correction of the hypoglycemia. This is often referred to as Whipple’s triad (Whipple, Can Med Assoc J 66:334–342, 1952) and such documentation must underpin the diagnosis of a hypoglycemic disorder.
In this chapter, we discuss the important aspects of hypoglycemic disorders, including clinical presentation, differential diagnosis, evaluation, and treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest. 2007;117(4):868–70.
Service FJ. Hypoglycemic disorders. N Engl J Med. 1995;332(17):1144–52.
Whipple AO. Islet cell tumors of the pancreas. Can Med Assoc J. 1952;66(4):334–42.
Towler DA, et al. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes. 1993;42(12):1791–8.
Amiel SA, et al. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes. 1988;37(7):901–7.
Boyle PJ, et al. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med. 1988;318(23):1487–92.
Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol. 1993;264(2 Pt 1):E149–55.
Heller SR, Cryer PE. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans. Am J Physiol. 1991;261(1 Pt 1):E41–8.
Service FJ. Diagnostic approach to adults with hypoglycemic disorders. Endocrinol Metab Clin North Am. 1999;28(3):519–32. vi.
Wilder RMA, Power MH. Carcinoma of the islands of the pancreas: hyperinsulinism and hypoglycemia. JAMA. 1927;89:348–55.
Service FJ, et al. Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711–9.
Nelson RL, Rizza RA, Service FJ. Documented hypoglycemia for 23 years in a patient with insulinoma. JAMA. 1978;240(17):1891.
Kar P, et al. Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia. J Clin Endocrinol Metab. 2006;91(12): 4733–6.
Power L. A glucose-responsive insulinoma. JAMA. 1969;207(5):893–6.
Service FJ, et al. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976;51(7):417–29.
Service FJ, et al. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab. 1999;84(5):1582–9.
Service GJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353(3):249–54.
Patti ME, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005;48(11):2236–40.
Basu A, et al. Insulin autoimmunity and hypoglycemia in seven white patients. Endocrine Pract. 2005;11(2):97–103.
Service FJ, Palumbo PJ. Factitial hypoglycemia. Three cases diagnosed on the basis of insulin antibodies. Arch Intern Med. 1974;134(2):336–40.
Marks V, Teale JD. Hypoglycemia: factitious and felonious. Endocrinol Metab Clin North Am. 1999;28(3):579–601.
Jordan RM, Kammer H, Riddle MR. Sulfonylurea-induced factitious hypoglycemia. A growing problem. Arch Intern Med. 1977;137(3):390–3.
Scarlett JA, et al. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N Engl J Med. 1977;297(19):1029–32.
Grunberger G, et al. Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up. Ann Intern Med. 1988;108(2):252–7.
Bates DW. Unexpected hypoglycemia in a critically ill patient. Ann Intern Med. 2002;137(2):110–6.
Larsson C, et al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 1988;332(6159):85–7.
Chandrasekharappa SC, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276(5311):404–7.
Bassett JH, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 1998;62(2):232–44.
Trump D, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM. 1996;89(9):653–69.
O’Riordain DS, et al. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg. 1994;18(4):488–93. discussion 493–4.
Samaan NA. Hypoglycemia secondary to endocrine deficiencies. Endocrinol Metab Clin North Am. 1989;18(1):145–54.
Shah P, Aniszweski J, Service FJ. Propoxyphene-induced hypoglycemia in renal failure. Endocr Pract. 2006;12(2):170–3.
Limburg PJ, et al. Quinine-induced hypoglycemia. Ann Intern Med. 1993;119(3):218–9.
Daughaday WH. Hypoglycemia in patients with non-islet cell tumors. Endocrinol Metab Clin North Am. 1989;18(1):91–101.
Katz LE, et al. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab. 1996;81(3):1141–6.
Teale JD, Marks V. Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH). Clin Endocrinol. 1998;49(4):491–8.
Perros P, et al. Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids. Clin Endocrinol. 1996;44(6):727–31.
Service FJ, O'Brien PC. Increasing serum betahydroxybutyrate concentrations during the 72-hour fast: evidence against hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab. 2005;90(8):4555–8.
Wiesli P, et al. Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations. J Vasc Interv Radiol. 2004;15(11):1251–6.
Basu A, et al. Insulinoma in chronic renal failure: a case report. J Clin Endocrinol Metab. 2002;87(11): 4889–91.
Noone TC, et al. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab. 2005;19(2):195–211.
McAuley G, et al. Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol. 2005;60(10):1039–50.
Fritscher-Ravens A. Endoscopic ultrasound and neuroendocrine tumours of the pancreas. JOP: J Pancr. 2004;5(4):273–81.
McLean AM, Fairclough PD. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab. 2005;19(2):177–93.
Grant CS. Surgical aspects of hyperinsulinemic hypoglycemia. Endocrinol Metab Clin North Am. 1999; 28(3):533–54.
Levy MJ, et al. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012;75(1):200–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Davidge-Pitts, C.J., Vella, A. (2014). Hypoglycemia in the Nondiabetic Patient. In: Bandeira, F., Gharib, H., Golbert, A., Griz, L., Faria, M. (eds) Endocrinology and Diabetes. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8684-8_33
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8684-8_33
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8683-1
Online ISBN: 978-1-4614-8684-8
eBook Packages: MedicineMedicine (R0)